Stock YSPSAH Y.S.P. SOUTHEAST ASIA HOLDING
Add to a list
To use this feature you must be a member
Log inSign up

Y.S.P. Southeast Asia Holding

Equities

YSPSAH

MYL7178OO006

Pharmaceuticals

End-of-day quote BURSA MALAYSIA
Other stock markets
 06:00:00 2024-07-15 pm EDT 		5-day change 1st Jan Change
2.89 MYR +1.05% Intraday chart for Y.S.P. Southeast Asia Holding +0.35% +25.65%
May. 23 YSP Southeast Asia's Q1 Profit Rises on Improved Revenue MT
May. 21 Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about Y.S.P. Southeast Asia Holding

YSP Southeast Asia's Q1 Profit Rises on Improved Revenue MT
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Y.S.P. Southeast Asia Holding Berhad Announces Final Single-Tier Special Dividend for the Financial Year Ended 31 December 2023, Payable on 22 July 2024 CI
Y.S.P. Southeast Asia Holding Berhad Announces Final Single-Tier Ordinary Dividend for the Financial Year Ended 31 December 2023, Payable on 22 Jul 2024 CI
Y.S.P. Southeast Asia Holding Bhd. Proposes First and Final Single-Tier Ordinary Dividend in Respect of Financial Year Ended 31 December 2023 CI
Y.S.P. Southeast Asia Holding Bhd. Proposes Special Dividend in Respect of Financial Year Ended 31 December 2023 CI
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
YSP Southeast Asia's Profit Plunges in Q3 MT
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Y.S.P. Southeast Asia Holding Berhad Announces Appointment of Mr. Lee Sen Huei as Independent and Non Executive Director CI
Y.S.P. Southeast Asia Holding Berhad Announces Retirement of Dr. Lee Fang Chuan @ Lee Fang Chen as Non Independent and Non Executive Director CI
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Y.S.P. Southeast Asia Holding Berhad Announces Final Single-Tier Special Dividend for the Financial Year Ended December 31, 2022, Payable on 25, 2023 CI
Y.S.P. Southeast Asia Holding Berhad Announces Final Single-Tier Ordinary Dividend for the Financial Year Ended December 31, 2022, Payable on July 25, 2023 CI
Y.S.P. Southeast Asia Holding Berhad Announces Resignation of Tu Shu Yao as Independent and Non Executive Director CI
Y.S.P. Southeast Asia Holding Berhad Announces Re-Designation of Yau Teck Kong to Independent and Non Executive Chairman of Nomination Committee CI
Y.S.P. Southeast Asia Holding Berhad Announces Resignation of Tu Shu Yao as Independent and Non Executive Member of Remuneration Committee CI
Y.S.P. Southeast Asia Holding Berhad Announces Resignation of Tu Shu Yao as Independent and Non Executive Chairman of Nomination Committee CI
Y.S.P. Southeast Asia Holding Berhad Announces Resignation of Tu Shu Yao as Independent and Non Executive Member of Audit Committee CI
Y.S.P. Southeast Asia Holding Berhad Proposes Special Dividend for the Financial Year Ended 31 December 2022 CI
Y.S.P. Southeast Asia Holding Berhad Proposes First and Final Single-Tier Ordinary Dividend for the Financial Year Ended 31 December 2022 CI
Y.S.P. Southeast Asia Holding Berhad Appoints Puan Hasnah Binti Ismail as Independent and Non Executive Member of Remuneration Committee CI
Y.S.P. Southeast Asia Holding Berhad Announces Datuk Dr. Anis Re-Designated from Chairman/Independent Director to Chairman/Non Independent and Non Executive Director CI
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Chart Y.S.P. Southeast Asia Holding

Chart Y.S.P. Southeast Asia Holding
More charts

Company Profile

Y.S.P. Southeast Asia Holding Berhad is a Malaysia-based healthcare company involved mainly in the trading and manufacturing of pharmaceutical products, particularly generic drugs. The Company, and its subsidiaries, carries a wide range of products, including pharmaceuticals, over the counter (OTC), veterinary and aquatic products, traditional complementary medicine (TCM), and food supplements in ASEAN, the Middle East, Africa, Australia, and New Zealand. The Company's segments include Manufacturing, Trading, and Investment Holding. The Manufacturing segment is engaged in the manufacturing of pharmaceutical products. The Trading segment is involved in the import, export and trading of various kinds of pharmaceutical, traditional herbal and veterinary products. The Investment Holding segment is involved in investment holding activities. Its subsidiaries include Y.S.P. (Cambodia) Pte. Ltd., Alpha Active Industries Sdn. Bhd., Y.S.P. Industries Vietnam Co., Ltd., and others.
Sector
Pharmaceuticals
Calendar
2024-08-27 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

1st Jan change Capi.
Y.S.P. SOUTHEAST ASIA HOLDING Stock Y.S.P. Southeast Asia Holding
+25.65% 86.84M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+25.40% 45.54B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+36.34% 24.51B
SANDOZ GROUP AG Stock Sandoz Group AG
+27.12% 16.48B
CIPLA LIMITED Stock Cipla Limited
+21.19% 14.66B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+71.91% 14.3B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-11.80% 6.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+15.08% 5.87B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. YSPSAH Stock
  4. News Y.S.P. Southeast Asia Holding
  5. YSP Southeast Asia's Q1 Profit Rises on Improved Revenue